Page last updated: 2024-08-25

1,2,3,4-tetrahydroquinoline and Ovarian Neoplasms

1,2,3,4-tetrahydroquinoline has been researched along with Ovarian Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abuskhuna, S; Benbrook, DM; Bhandari, D; Bunce, RA; Darrell Berlin, K; Gnanasekaran, KK; Mashayekhi, M; Pouland, T; Zhou, DH1

Other Studies

1 other study(ies) available for 1,2,3,4-tetrahydroquinoline and Ovarian Neoplasms

ArticleYear
Tetrahydroquinoline units in flexible heteroarotinoids (Flex-Hets) convey anti-cancer properties in A2780 ovarian cancer cells.
    Bioorganic & medicinal chemistry, 2020, 01-01, Volume: 28, Issue:1

    Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Proliferation; Chromans; Female; Humans; Molecular Docking Simulation; Ovarian Neoplasms; Quinolines; Structure-Activity Relationship; Thiones; Urea

2020